Glycosidase-activated H2S donorsto enhance chemotherapy efficacy
Bioorganic & Medicinal Chemistry Letters · 2024
DOI: 10.1016/j.bmcl.2024.129644 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry Letters, 2024. Verfasst von Zizhen Ye und 5 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory on Technologies Enabling Development of ClinicalTherapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, …. Hauptthemen laut MEDLINE: Hydrogen Sulfide. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Hydrogen sulfide (H2S) plays a critical role in cancer biology. Herein, we developed a series of glycosidase-triggered hydrogen sulfide (H2S) donors by connecting sugar moieties (including glucose, galactose and mannose) to COS donors via a self-immolative spacer. In the presence of corresponding glycosidases, H2S was gradually released from these donors in PBS buffer with releasing efficiencies from 36 to 67 %. H2S release was also detected by H2S probe WSP-1 after treatment HepG2 cells with Man1. Cytotoxicities of these glycosylated H2S donors were evaluated against HepG2 by MTT assay. Among them, Man1 and Man2 exhibited an obvious reduction of cell viability in HepG2 cells, with cell viability as 37.6 % for 80 μM of Man. Consistently, significant apoptosis was observed in HepG2 cells after treatment with Man1 and Man2. Finally, We evaluated the potential of Man1 for combination therapy with doxorubicin. A synergistic effect was observed between Man1 and Doxorubicin in HepG2 and Hela cells. All these results indicated glycosidase-activated H2S donorshave promising potential for cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Tianjin Key Laboratory on Technologies Enabling Development of ClinicalTherapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin 300070, PR China.
- Tianjin Key Laboratory on Technologies Enabling Development of ClinicalTherapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin 300070, PR China. Electronic address: liuyangping@tmu.edu.cn.
- Tianjin Key Laboratory on Technologies Enabling Development of ClinicalTherapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin 300070, PR China. Electronic address: houjingli@tmu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ye, Z., Li, J., Shi, J., Song, Y., Liu, Y., & Hou, J. (2024). Glycosidase-activated H2S donorsto enhance chemotherapy efficacy. Bioorganic & Medicinal Chemistry Letters. https://doi.org/10.1016/j.bmcl.2024.129644
Vancouver
Ye Z, Li J, Shi J, Song Y, Liu Y, Hou J. Glycosidase-activated H2S donorsto enhance chemotherapy efficacy. Bioorganic & Medicinal Chemistry Letters. 2024. doi:10.1016/j.bmcl.2024.129644
BibTeX
@article{Ye2024,
author = {Ye, Zizhen and Li, Jixiang and Shi, Jiarui and Song, Yuguang and Liu, Yangping and Hou, Jingli},
title = {Glycosidase-activated H2S donorsto enhance chemotherapy efficacy},
journal = {Bioorganic & Medicinal Chemistry Letters},
year = {2024},
doi = {10.1016/j.bmcl.2024.129644}
}
EUVIMED